Novavax, Inc.
9.70USD
-0.2900 (-2.90%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on NVAX.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | -$0.22▼ | -$0.02 | 1 | 1 |
| Next quarter | -$0.05▲ | -$0.08 | 0 | 1 |
| Current year | -$0.52▼ | -$0.47 | 0 | 1 |
| Next year | -$0.08▲ | -$0.25 | 1 | 0 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | -$0.38 | -$0.32 | +0.06 (+16.6%) |
| 2026-03-31 | -$0.24 | -$0.06 | +0.18 (+75.2%) |
| 2025-12-31 | -$0.49 | $0.11 | +0.60 (+122.5%) |
| 2025-09-30 | -$1.17 | -$1.25 | -0.08 (-7.0%) |
114 ratings from 18 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Citigroup | Maintained | Sell | $7 $8 | Oct 15, 2026 |
| BTIG | Reiterated | Buy | $19 | Jun 11, 2026 |
| TD Cowen | Maintained | Hold | $8 $9 | May 6, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $11 $16 | Feb 27, 2026 |
| BTIG | Reiterated | Buy | $19 | Jan 20, 2026 |
| JP Morgan | Maintained | Underweight | $7 $6 | Nov 18, 2025 |
| B. Riley Securities | Reiterated | Buy | $18 $16 | Nov 10, 2025 |
| TD Cowen | Maintained | Hold | $8 $7 | Nov 4, 2025 |
| Cantor Fitzgerald | Initiated | Overweight | $18 | Oct 24, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $10 $11 | Oct 23, 2025 |
| B of A Securities | Downgraded from Neutral | Underperform | $9 $7 | Aug 20, 2025 |
| B of A Securities | Maintained | Neutral | $10 $9 | Jul 22, 2025 |
| Citigroup | Initiated | Sell | $6 | Jun 17, 2025 |
| JP Morgan | Maintained | Underweight | $9 $7 | May 9, 2025 |
| HC Wainwright & Co. | Reiterated | Buy | $19 | Dec 10, 2024 |
| HC Wainwright & Co. | Reiterated | Buy | $19 | Nov 13, 2024 |
| HC Wainwright & Co. | Reiterated | Buy | $19 | Nov 12, 2024 |
| B. Riley Securities | Reiterated | Buy | $25 $23 | Aug 12, 2024 |
| JP Morgan | Maintained | Underweight | $8 $9 | Aug 12, 2024 |
| B. Riley Securities | Maintained | Buy | $29 $25 | Aug 2, 2024 |
| JP Morgan | Downgraded from Neutral | Underweight | $8 | Jul 30, 2024 |
| B of A Securities | Maintained | Neutral | $12 $18 | Jun 14, 2024 |
| B. Riley Securities | Maintained | Buy | $11 $29 | May 23, 2024 |
| TD Cowen | Maintained | Hold | $5 $10 | May 13, 2024 |
| HC Wainwright & Co. | Reiterated | Buy | $19 | May 13, 2024 |
43 filings from 15 insiders · 0 buy / 0 sell over 6m
Officers and directors of NVAX, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| MOTT DAVID MDirector | Other | 18.9k | — | — | Jun 18, 2026 |
| RODGERS RICHARD J.Director | Other | 18.9k | — | — | Jun 18, 2026 |
| ALTON GREGG HDirector | Other | 18.9k | — | — | Jun 18, 2026 |
| MCGLYNN MARGARET GDirector | Other | 18.9k | — | — | Jun 18, 2026 |
| DOUGLAS RICHARD HDirector | Other | 18.9k | — | — | Jun 18, 2026 |
| KING RACHEL KDirector | Other | 18.9k | — | — | Jun 18, 2026 |
| NEWTON CHARLES W.Director | Other | 9.5k | — | — | Apr 24, 2026 |
| SHIVER JOHN W. PH.D.Director | Other | 7.9k | — | — | Mar 10, 2026 |
| KELLY JAMES PATRICKChief Financial Officer | Other | 12.2k | — | — | Mar 6, 2026 |
| CASEY MARK JOfficer | Other | 37.5k | — | — | Mar 3, 2026 |
| KELLY JAMES PATRICKChief Financial Officer | Other | 43.2k | — | — | Mar 3, 2026 |
| JACOBS JOHN CChief Executive Officer | Other | 150.2k | — | — | Mar 3, 2026 |
| O'HARA ELAINEOfficer | Other | 56.3k | — | — | Mar 3, 2026 |
| DRAGHIA-AKLI RUXANDRAOfficer | Other | 26.7k | — | — | Mar 3, 2026 |
| CASEY MARK JOfficer | Other | 4.0k | — | — | Feb 27, 2026 |
| KELLY JAMES PATRICKChief Financial Officer | Other | 58.7k | — | — | Feb 27, 2026 |
| JACOBS JOHN CChief Executive Officer | Other | 83.3k | — | — | Feb 27, 2026 |
| O'HARA ELAINEOfficer | Other | 59.6k | — | — | Feb 27, 2026 |
| JACOBS JOHN CChief Executive Officer | Other | 83.2k | — | — | Jan 23, 2026 |
| CASEY MARK JOfficer | Other | 41.9k | — | — | Dec 11, 2025 |
No analyst notes on NVAX yet.
Analyst Ratings
9 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 0 | 5 | 1 | 1 | 2 | Hold3.00 |
| 1 mo ago | 0 | 5 | 1 | 1 | 2 | Hold3.00 |
| 2 mo ago | 0 | 5 | 1 | 1 | 2 | Hold3.00 |
| 3 mo ago | 0 | 5 | 1 | 1 | 2 | Hold3.00 |
Members whose judged calls on NVAX have played out most reliably.
No settled calls on NVAX yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice